The relationship between tumor necrosis factor-α and insulin resistance in patients with type 2 diabetes
Zeng Shun
Abstract
Zeng Shun
Abstract
Objective:To study the relationship between tumor necrosis factor-α(TNF-α)and insulin resistance in the serum of type2diabetes.Methods:The fasting blood glucose,fasting blood-insulin and serum TNF-αin23healthy persons(control group)and22type2diˉabetes patients were respectively measured by oxidase method,RIA and ELISA,and compared between two groups.The insulin sensitivity index(ISI)was calcuated.Results:The level of TNF-αin type2diabetes group was significantly higher than that in control group(P0.01),but ISI was lower(P0.01).Conclusion:In type2diabetes patients,the increase of TNF-αlevel is related to insulin resistance,which plays an imˉportant role in the occurrence and development of this disease.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the relationship between tumor necrosis factor-α(TNF-α)and insulin resistance in the serum of type2diabetes.Methods:The fasting blood glucose,fasting blood-insulin and serum TNF-αin23healthy persons(control group)and22type2diˉabetes patients were respectively measured by oxidase method,RIA and ELISA,and compared between two groups.The insulin sensitivity index(ISI)was calcuated.Results:The level of TNF-αin type2diabetes group was significantly higher than that in control group(P0.01),but ISI was lower(P0.01).Conclusion:In type2diabetes patients,the increase of TNF-αlevel is related to insulin resistance,which plays an imˉportant role in the occurrence and development of this disease.
Key concepts: Medicine, Insulin resistance, Internal medicine, Tumor necrosis factor alpha, Endocrinology, Tumor necrosis factor α, Type 2 diabetes, Insulin